Adial Pharmaceuticals, Inc.
ADIL· Nasdaq
ADILAdial Pharmaceuticals, Inc.
Who holds Adial Pharmaceuticals, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 32.1K | New | $82.2K | 0% | Aug 14, 2026 |
| Citadel Advisors LLC | 29.5K | New | $75.6K | 0% | Sep 2, 2026 |
| UBS Group AG | 19.1K | +3,432.7% | $49K | 0% | Aug 13, 2026 |
| StoneX Group Inc. | 19.7K | New | $35.7K | 0.1% | Aug 12, 2026 |
| Geode Capital Management, LLC | 12.4K | −48.9% | $31.7K | 0% | Aug 12, 2026 |
| China Universal Asset Management Co., Ltd. | 8K | New | $20.5K | 0.1% | Jul 24, 2026 |
| Vanguard Fiduciary Trust Co | 5.9K | ±0% | $15.1K | 0% | Aug 13, 2026 |
| Vanguard Capital Management LLC | 5.8K | +1,515.2% | $14.9K | 0% | Aug 13, 2026 |
| Manchester Capital Management LLC | 1.9K | ±0% | $4.9K | 0.1% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 1.4K | +4.6% | $3.6K | 0.1% | Aug 11, 2026 |
| BlackRock, Inc. | 304 | −72.6% | $778 | 0% | Aug 7, 2026 |
| Raffa Wealth Management, LLC | 83 | ±0% | $212 | 0% | Jul 27, 2026 |
| Morgan Stanley | 50 | ±0% | $128 | 0% | Aug 13, 2026 |
| SBI Securities Co., Ltd. | 47 | ±0% | $120 | 0% | Jul 23, 2026 |
| Wells Fargo & Company | 6 | ±0% | $15 | 0% | Aug 14, 2026 |
| Harbour Investments, Inc. | 3 | ±0% | $8 | 0% | Aug 12, 2026 |
| Abound Wealth Management | 1 | ±0% | $3 | 0% | Jul 10, 2026 |
